Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer ; volume:11 ; number:1 ; day:16 ; month:3 ; year:2011 ; pages:1-8 ; date:12.2011
BMC cancer ; 11, Heft 1 (16.3.2011), 1-8, 12.2011
- Creator
-
Cellier, Patrice
- Contributor
-
Leduc, Bernard
Martin, Laurent
Vié, Brigitte
Chevelle, Christian
Vendrely, Véronique
Salemkour, Augustin
Carrie, Christian
Calais, Gilles
Burtin, Pascal
Campion, Loïc
Boisdron-Celle, Michèle
Morel, Alain
Berger, Virginie
Gamelin, Erick
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-11-98
- URN
-
urn:nbn:de:1111-2016030363866
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cellier, Patrice
- Leduc, Bernard
- Martin, Laurent
- Vié, Brigitte
- Chevelle, Christian
- Vendrely, Véronique
- Salemkour, Augustin
- Carrie, Christian
- Calais, Gilles
- Burtin, Pascal
- Campion, Loïc
- Boisdron-Celle, Michèle
- Morel, Alain
- Berger, Virginie
- Gamelin, Erick
- SpringerLink (Online service)
Other Objects (12)
A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis
Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
Benefits of pre-operative concurrent chemo-radiotherapy among elder patients with local advanced rectal cancer
Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial
Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer
Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer
A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis
Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
Benefits of pre-operative concurrent chemo-radiotherapy among elder patients with local advanced rectal cancer
Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial
Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer
Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer
A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis
Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
Benefits of pre-operative concurrent chemo-radiotherapy among elder patients with local advanced rectal cancer
Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial
Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer